Home death as a negative indicator of end-of-life care in Brazil: author's response to Hong et al.

Jess�� Lopes da Silva, L��via Costa de Oliveira, Lucas Zanetti de Albuquerque, Luiz Claudio Santos Thuler, Andr��ia Cristina de Melo
Author Information
  1. Jess�� Lopes da Silva: Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  2. L��via Costa de Oliveira: Palliative Care Unit, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  3. Lucas Zanetti de Albuquerque: Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  4. Luiz Claudio Santos Thuler: Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  5. Andr��ia Cristina de Melo: Division of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.

Abstract

No abstract text available.

References

  1. Inquiry. 2022 Jan-Dec;59:469580221088627 [PMID: 35502776]
  2. JAMA Netw Open. 2024 Jan 2;7(1):e2350821 [PMID: 38190187]
  3. Lancet Reg Health Am. 2024 May 14;34:100764 [PMID: 38779656]
  4. Lancet Reg Health Am. 2024 Jul 26;36:100846 [PMID: 39170859]

Word Cloud

Created with Highcharts 10.0.0Homedeathnegativeindicatorend-of-lifecareBrazil:author'sresponseHonget al

Similar Articles

Cited By

No available data.